What is William Blair's Estimate for Neogen FY2025 Earnings?

Neogen Co. (NASDAQ:NEOG - Free Report) - Investment analysts at William Blair dropped their FY2025 earnings estimates for Neogen in a report released on Monday, April 14th. William Blair analyst B. Vazquez now forecasts that the company will post earnings of $0.31 per share for the year, down from their prior forecast of $0.32. The consensus estimate for Neogen's current full-year earnings is $0.38 per share. William Blair also issued estimates for Neogen's Q4 2025 earnings at $0.08 EPS, FY2026 earnings at $0.36 EPS and FY2027 earnings at $0.42 EPS.

Neogen (NASDAQ:NEOG - Get Free Report) last issued its quarterly earnings results on Wednesday, April 9th. The company reported $0.10 earnings per share for the quarter, missing analysts' consensus estimates of $0.12 by ($0.02). The business had revenue of $221.00 million for the quarter, compared to analysts' expectations of $225.27 million. Neogen had a positive return on equity of 2.89% and a negative net margin of 52.12%. The company's revenue for the quarter was down 3.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.12 EPS.

A number of other equities analysts have also weighed in on NEOG. Guggenheim decreased their price target on shares of Neogen from $15.00 to $13.00 and set a "buy" rating on the stock in a report on Thursday, April 10th. Piper Sandler reduced their target price on Neogen from $13.00 to $6.50 and set a "neutral" rating on the stock in a report on Monday, April 14th.

Neogen Trading Up 3.6 %

NEOG traded up $0.16 during midday trading on Wednesday, hitting $4.55. The company's stock had a trading volume of 4,263,549 shares, compared to its average volume of 2,648,589. The firm has a 50-day moving average price of $8.51 and a two-hundred day moving average price of $11.54. The company has a current ratio of 3.77, a quick ratio of 2.46 and a debt-to-equity ratio of 0.33. Neogen has a 52-week low of $3.87 and a 52-week high of $18.58. The firm has a market cap of $987.52 million, a P/E ratio of -2.08 and a beta of 1.57.

Institutional Investors Weigh In On Neogen

Several hedge funds have recently modified their holdings of NEOG. Connable Office Inc. raised its stake in shares of Neogen by 5.6% during the fourth quarter. Connable Office Inc. now owns 18,793 shares of the company's stock valued at $228,000 after purchasing an additional 1,000 shares during the period. Covestor Ltd lifted its holdings in Neogen by 41.4% in the 4th quarter. Covestor Ltd now owns 4,103 shares of the company's stock worth $50,000 after buying an additional 1,202 shares in the last quarter. Inspire Advisors LLC boosted its position in Neogen by 10.1% in the 4th quarter. Inspire Advisors LLC now owns 14,226 shares of the company's stock valued at $173,000 after buying an additional 1,304 shares during the last quarter. CHICAGO TRUST Co NA increased its position in shares of Neogen by 19.1% during the first quarter. CHICAGO TRUST Co NA now owns 12,498 shares of the company's stock worth $108,000 after acquiring an additional 2,000 shares during the last quarter. Finally, Ascent Group LLC lifted its stake in shares of Neogen by 17.8% in the fourth quarter. Ascent Group LLC now owns 14,340 shares of the company's stock worth $174,000 after acquiring an additional 2,165 shares in the last quarter. 96.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, CAO John Patrick Moylan acquired 10,000 shares of Neogen stock in a transaction on Thursday, April 10th. The shares were bought at an average price of $5.07 per share, for a total transaction of $50,700.00. Following the completion of the purchase, the chief accounting officer now directly owns 10,000 shares in the company, valued at $50,700. This trade represents a ∞ increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 1.13% of the company's stock.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.